What more can you say about Janet Woodcock? The US Food and Drug Administration’s principal deputy commissioner, who will soon be retiring after 37 extraordinary years at the agency, has meant so much to the agency and industry that it can seem hard to find the words to express our sentiments. Woodcock’s departure isn’t exactly a wedding or a funeral, but it remains a very emotional life event for many in the pharmaceutical family.
Pink Sheet's Sarah Karlin-Smith penned a masterful 2021 profile and her story last year on the news of...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?